In a study involving elderly individuals with memory impairment, those carrying the APOC1 risk genotype exhibited smaller HV compared to non-carriers, suggesting that APOC1 variants may contribute to AD-like neurodegeneration [25]. This evidence concerns the gene APOC1 and Alzheimer disease.